1.
Abdoli Shadbad M, Baghbanzadeh A, Baradaran B. hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study. EXCLI J. [Internet]. 2024 Mar. 13 [cited 2024 May 8];23:384-400. Available from: https://www.excli.de/index.php/excli/article/view/6404